Comparison between vildagliptin and metformin to sustain reductions in HbA(1c) over 1 year in drug-naive patients with Type 2 diabetes
There are an estimated 2 million Americans taking compounded versions of the drugs, according to the Kaiser Family Foundation
A JAMA Network Open retrospective cohort study of 125,474 adults with overweight or obesity: Patients with T2DM: 46.5% discontinued by year one 64.1% discontinued by year two Patients without T2DM: 64.8% discontinued by year one 84.4% discontinued by year two Nearly 85% of patients without diabetes stopped taking GLP-1s within two years
Stimulating GLP has multiple effects which impact weight, including decreased insulin resistance, slower gastrointestinal transit time, and decreased hunger and cravings. By reducing appetite and silencing food noise, Ozempic can help you eat less, feel more satisfied at meals, and focus on optimal nutrition
This term refers to the practice of a healthcare provider using their clinical judgment to prescribe a specific medication for an indication that the FDA has not approved